Dr. Carpizo is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
601 Elmwood Ave
Rochester, NY 14642Phone+1 585-275-1984- Is this information wrong?
Education & Training
- UCLA David Geffen School of Medicine/UCLA Medical CenterResidency, Surgery, 1997 - 2006
- University of Illinois College of MedicineClass of 1997
Certifications & Licensure
- CA State Medical License 1999 - Present
- NY State Medical License 2006 - 2025
- NJ State Medical License 2008 - 2021
- American Board of Surgery Surgery
Awards, Honors, & Recognition
- Fellow (FACS) American College of Surgeons
Clinical Trials
- A Pilot Study of a Hedgehog Pathway Inhibitor (LDE-225) in Surgically Resectable Pancreas Cancer Start of enrollment: 2012 Nov 01
- A Trial of Perioperative CV301 Vaccination in Combination With Nivolumab and Systemic Chemotherapy for Metastatic CRC Start of enrollment: 2018 Jun 26
- Pancreatic Cancer Early Detection Consortium Start of enrollment: 2020 Sep 18
Roles: Principal Investigator
Publications & Presentations
PubMed
- Transforming the Future of Surgeon-Scientists.Ladner, D., Goldstein, A., Billiar, T., Cameron, A., Carpizo, D., Chu, D., Coopersmith, C., DeMatteo, R., Feng, S., Gallagher, K., Gillanders, W., Lal, B., Lipshutz, G...> ;Annals of Surgery. 2024 Feb 1
- Identifying the optimal treatment strategy in patients with resectable non-cardia gastric cancer.Pranay S Ajay, Raja Kumaran Rajamanickam, Kevin Rhee, Rachel NeMoyer, Subir Goyal, Jeffery M Switchenko, Yong Lin, Salma K Jabbour, Darren R Carpizo, Timothy J Kennedy...> ;Surgical Endoscopy. 2024 Jan 1
- 1 citationsNetrin-1 feedforward mechanism promotes pancreatic cancer liver metastasis via hepatic stellate cell activation, retinoid, and ELF3 signaling.Crissy Dudgeon, Anthony Casabianca, Chris Harris, Charline Ogier, Mélanie Bellina, Stephany Fiore, Agnes Bernet, Benjamin Ducarouge, David Goldschneider, Xiaoyang Su, ...> ;Cell Reports. 2023 Nov 28
- Join now to see all
Journal Articles
- Neoadjuvant Chemoradiation Improves Margin Positivity Rates After Pancreaticoduodenectomy in T1 and T2 Resectable Pancreatic Cancer: An Analysis of the National Cancer...Mihir M Shah, Darren R Carpizo, Miral S Grandhi, Russell C Langan, Journal of The American College of Surgeons
Authored Content
- Neoadjuvant Chemoradiation Improves Margin Positivity Rates After Pancreaticoduodenectomy in T1 and T2 Resectable Pancreatic Cancer: An Analysis of the National Cancer DatabaseOctober 2018
Press Mentions
- $500K Grant Aids Exploration of Genetic Changes in Pancreatic Cancer for New Treatment TargetsAugust 23rd, 2018
- Meet Our 2018 Research Grantees: Translational AwardsJuly 18th, 2018
- Bavarian Nordic Announces Initiation of Phase 2 Trial Evaluating the Combination Therapy of CV301 and Nivolumab in Metastatic Colorectal CancerJuly 11th, 2018
- Join now to see all
Professional Memberships
- Member
Hospital Affiliations
- Strong Memorial Hospital of the University of RochesterRochester, New York
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: